CLINICAL_TRIALS
trial_result
· 2014-06-17
Clinical Trial Update: Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer [Phase 3]
Summary
Phase III study of docetaxel with ramucirumab versus placebo in breast cancer has completed with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2014-06-17